|
Jayesh Kamath, M.D., Ph.D.Associate Professor, Psychiatry
|
|
||||||
Education
Post-Graduate Training
Awards
| Degree | Institution | Major |
|---|---|---|
| Other | Ruparel College | Biology/Chemistry |
| M.D. | St. Petersburg Pavlov State Medical University | Medicine |
| Ph.D. | University of Arizona | Immunology/Cancer Biology |
Post-Graduate Training
| Training | Institution | Specialty |
|---|---|---|
| Internship | University of Connecticut School of Medicine | |
| Residency | University of Connecticut School of Medicine | Psychiatry |
| Residency | University of Connecticut School of Medicine | Chief Resident, Psychiatry (Outpatient) |
| Fellowship | University of Connecticut School of Medicine | Psychopharmacology/Research |
| Professional Training | University of Connecticut Health Center | Certificate of Added Qualifications “Principles of Clinical Research” Sponsored by the General Clinical Research Center (GCRC) |
| Professional Training | University of Connecticut Health Center | Certificate of Training for Vagal Nerve Stimulation (VNS) |
Awards
| Name of Award/Honor | Awarding Organization |
|---|---|
| Career Development Institute (CDI) for Bipolar Disorder Award, to Attend NIMH Aponsored CDI for BD at the University of Pittsburgh, Pittsburgh, PA | |
| Research Colloquium for Junior Investigators Travel Award, New Orleans, LA | American Psychiatric Association |
| New Investigator Award, Awarded at the New Clinical Drug Evaluation Unit (NCDEU) Meeting, Boca Raton, FL | National Institute of Mental Health (NIH) |
| Scholarship in Research Award | University of Connecticut Health Center |
| International Medical Graduate Mentorship Award in Psychiatry | American Association of Directors of Psychiatric Residency Training (AADPRT) |
| Name & Description | Category | Role | Type | Scope | Start Year | End Year |
|---|---|---|---|---|---|---|
| Caner Committee, Neag Comprehensive Cancer Center, University of Connecticut Health Center | Professional/Scientific Organization | Member | UConn Health | University | 2010 | |
| New Jersey Commission on Cancer Research (NJCCR) | Advisory Committee | Ad Hoc Reviewer | External | State | 2009 | |
| Pharmacy & Therapeutic Committee for the University of Connecticut Health Center | Professional/Scientific Organization | Committee Member | UConn Health | University | 2008 | |
| National Cancer Institute (NCI) Supportive and Palliative Care Editorial Board (http://www.cancer.gov/cancerinfo/pdq/supportive-care-board) | Editorial Board | Editorial Board | External | National | 2006 | |
| International Psycho-Oncology Society | Professional/Scientific Organization | Member | External | International | 2005 | |
| Psychopharmacology consultant for the Connecticut Department of Correction (DOC) | Advisory Committee | Consultant | External | State | 2005 | |
| Pharmacy & Therapeutic Committee for the Connecticut Department of Correction | Professional/Scientific Organization | Member | External | State | 2005 | |
| American Psychiatric Association | Professional/Scientific Organization | Member | External | National | 2003 |
Journal Articles
-
Atomoxetine for the Treatment of ADHD in Incarcerated Adolescents.
The journal of the American Academy of Psychiatry and the Law 2016 Jun;44(2):158-63
-
Adaptation of the Texas Implementation Medication Algorithm for Bipolar Disorder in Adult Female Offenders.
International journal of offender therapy and comparative criminology 2015 Mar;
-
Algorithm-driven pharmacological management of bipolar disorder in Connecticut prisons.
International journal of offender therapy and comparative criminology 2013 Feb;57(2):251-64
-
Thyrotropin-releasing hormone as a treatment for cancer-related fatigue: a randomized controlled study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012 Aug;20(8):1745-53
-
Symptom distress associated with biopsy in women with suspect breast lesions.
ISRN oncology 2012 Jan;2012898327
-
Thyrotropin-releasing hormone can relieve cancer-related fatigue: hypothesis and preliminary observations.
The Journal of international medical research 2009 Jan;37(4):1152-7
-
Psychiatric use and utility of divalproex sodium in Connecticut prisons.
International journal of offender therapy and comparative criminology 2008 Jun;52(3):358-70
-
Efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder
Future Neurology 2007 Jan;2(4):361-371
-
Thyrotropin-releasing hormone (TRH) in the neuroaxis: therapeutic effects reflect physiological functions and molecular actions.
Medical hypotheses 2007 Jan;69(6):1249-56
Conference Papers
-
Medication adherence among female inmates with bipolar disorder: results from a randomized controlled trial.
Psychological services 2013 Feb;10(1):106-14
-
Evidence-Based Treatment Of Bipolar Disorder In Connecticut Prison: A Two-Phase Study.
2009 Jan;
Editorials
-
Sleep Disorders and Mental Health.
The Psychiatric clinics of North America 2015 Dec;38(4):xiii-xiv
Reviews
-
Sleep Disturbances in Patients with Medical Conditions.
The Psychiatric clinics of North America 2015 Dec;38(4):825-41
-
Sleep Disturbances in Schizophrenia.
The Psychiatric clinics of North America 2015 Dec;38(4):777-92
-
The thyrotropin-releasing hormone (TRH)-immune system homeostatic hypothesis.
Pharmacology & therapeutics 2009 Jan;121(1):20-8
-
Desvenlafaxine succinate for major depressive disorder: a critical review of the evidence.
Expert review of neurotherapeutics 2008 Dec;8(12):1787-97